Skip to main content
Medica logo

Medica — Investor Relations & Filings

Ticker · MDC ISIN · IT0005460149 LEI · 815600FE16FA9F3E2296 XMIL Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2025-11-26 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL MDC

About Medica

https://www.medica.it/

Medica S.p.A. is a company specializing in advanced purification technologies. Its core business is the development and production of products for blood purification, with applications in dialysis, Continuous Renal Replacement Therapy (CRRT), and apheresis. The company's medical product portfolio includes polysulfone membranes, dialysis filters, hemofilters, and blood lines. It has expanded its expertise into other medical fields such as cardiology, oncology surgery, organ transplantation, urology, and gastroenterology. Leveraging its filtration know-how, Medica also operates a water purification division that produces hollow fiber membranes. Additionally, the company offers turnkey solutions for the biomedical sector, providing vertically integrated services from research and development to manufacturing, industrial automation, and regulatory management.

Recent filings

Filing Released Lang Actions
COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE
Share Issue/Capital Change Classification · 100% confidence The document is a 'COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE' (Interim communication during the stabilization period) issued by Più Medical S.p.A. It details specific stabilization transactions conducted by Banca Investis S.p.A. following an IPO on Euronext Growth Milan, as required by EU Market Abuse Regulation (MAR) and Delegated Regulation (EU) 2016/1052. Since this is a regulatory disclosure regarding market stabilization activities and does not fit into categories like earnings releases or annual reports, it is classified as a Regulatory Filing.
2025-11-26 English
PIÙ MEDICAL ADMITTED TO TRADING ON EURONEXT GROWTH MILAN
Delisting Announcement Classification · 100% confidence The document is a press release announcing the admission of Più Medical S.p.A. shares to trading on the Euronext Growth Milan exchange. It details the market capitalization, the placement process, the share capital composition, and includes standard regulatory disclaimers regarding stabilization and distribution. As it is an announcement of a corporate event (IPO/listing) rather than a formal financial report or a specific regulatory filing like a 10-K, it falls under the category of general regulatory announcements or corporate news.
2025-11-18 English
PIÙ MEDICAL AMMESSA ALLE NEGOZIAZIONI SU EURONEXT GROWTH MILAN
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing that Più Medical S.p.A. has been admitted to trading on the Euronext Growth Milan exchange. It details the capitalization, the share structure, the date of the start of trading, and lists the advisors involved in the IPO process. This is a corporate announcement regarding a capital market event (IPO/listing), which falls under the category of share issuance or capital changes.
2025-11-18 English
OPA Medica - Comunicato stampa deposito corrispettivo Procedura Congiunta
Delisting Announcement Classification · 99% confidence The document is a formal communication from MavenDanc S.r.l. regarding a voluntary takeover bid (Offerta pubblica di acquisto volontaria totalitaria) for Medica S.p.A. Specifically, it announces the completion of the joint procedure for exercising the right to purchase remaining shares (squeeze-out/sell-out rights under Italian TUF articles 111 and 108) and the subsequent delisting of Medica shares. This content relates directly to a takeover bid, merger proposal, or significant transaction involving share control. Based on the definitions, 'M&A Activity (Code: TAR)' is the most appropriate classification for documents detailing the final stages or results of a takeover bid or merger proposal.
2024-08-14 Italian
OPA Medica - Comunicato stampa (Risultati definitivi dell'Offerta e Procedura Congiunta)
Delisting Announcement Classification · 99% confidence The document is a formal communication titled "RISULTATI DEFINITIVI DELL'OFFERTA" (Final Results of the Offer) concerning a voluntary takeover bid (Offerta pubblica di acquisto volontaria totalitaria) by MavenDanc S.r.l. for shares of Medica S.p.A. It details the final acceptance rates, the fulfillment of offer conditions, the payment date for tendered shares, and the initiation of the mandatory buy-out procedure (Obbligo di Acquisto ai sensi dell'articolo 108, comma 1, del TUF) for remaining shares. This content directly relates to a takeover bid and subsequent mandatory acquisition of shares, which falls under the category of M&A Activity (TAR). It is not a general regulatory filing (RNS) because it is highly specific to a takeover process, nor is it a simple share transaction report (POS) as it details the entire tender offer outcome and subsequent mandatory steps.
2024-08-07 Italian
OPA Medica - Comunicato risultati provvisori dell'offerta
Delisting Announcement Classification · 99% confidence The document is an official communication from MavenDanc S.r.l. regarding the provisional results of a 'Offerta pubblica di acquisto volontaria totalitaria' (Total Voluntary Public Purchase Offer) for the shares of Medica S.p.A. It explicitly mentions reaching the 90% capital threshold, which triggers the right of purchase and obligation to buy out remaining shares, and discusses the potential delisting. This subject matter—a takeover bid or merger proposal—directly corresponds to the definition of M&A Activity (TAR). Although it is a result announcement, the core subject is the takeover transaction itself, making TAR more specific than a general RPA or RNS.
2024-08-05 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.